Mersana Therapeutics Inc.

08/16/2022 | Press release | Distributed by Public on 08/16/2022 06:18

Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-1660 in Breast, Endometrial and Ovarian Cancers - Form 8-K